Aardvark Therapeutics, Inc. (AARD)
NASDAQ: AARD · Real-Time Price · USD
12.72
-0.76 (-5.64%)
At close: Feb 10, 2026, 4:00 PM EST
12.61
-0.11 (-0.86%)
After-hours: Feb 10, 2026, 4:10 PM EST
Aardvark Therapeutics Market Cap
Aardvark Therapeutics has a market cap or net worth of $276.96 million as of February 10, 2026.
Market Cap
276.96M
Enterprise Value
157.25M
1-Year Change
n/a
Ranking
Category
Stock Price
$12.72
Market Cap Chart
Since the IPO on February 13, 2025, Aardvark Therapeutics's market cap has decreased from $342.15M to $276.96M, a decrease of -19.05%. That is a compound annual growth rate of -19.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 293.50M | 2.70% |
| Dec 31, 2025 | 285.77M | -16.48% |
| Feb 13, 2025 | 342.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Armata Pharmaceuticals | 293.62M |
| Rezolute | 293.02M |
| Larimar Therapeutics | 292.72M |
| XOMA Royalty | 285.00M |
| Abeona Therapeutics | 284.23M |
| Minerva Neurosciences | 277.61M |
| Cellectis | 274.60M |
| Nautilus Biotechnology | 270.92M |